Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 19555288.
- Also identified by DOI 10.1086/600398 and PMC identifier 2712125.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Menopause may affect antiretroviral treatment (ART) response. Immunologic and virologic responses to ART were compared in 220 premenopausal and 47 postmenopausal women enrolled in 2 studies involving ART-naive persons. Changes in CD4 counts or human immunodeficiency virus type 1 RNA levels were similar at 24, 48, and 96 weeks after treatment initiation. ART-naive women should respond to ART regardless of menopausal status.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- Antiretroviral Therapy, Highly Active
- HIV-1